Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Market Closed - OTC Markets
Other stock markets
 03:59:44 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.00318 USD -5.07% Intraday chart for RespireRx Pharmaceuticals Inc. +357.14% +255.56%
Apr. 10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
Mar. 20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI

Chart: Technical Analysis

  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Charts RespireRx Pharmaceuticals Inc.